Total Payments
$978,724
2024 Payments
$85,098
Companies
46
Transactions
1,170
Medicare Patients
5,852
Medicare Billing
$434,965
Payment Breakdown by Category
Research$383,540 (39.2%)
Consulting$314,483 (32.1%)
Other$225,126 (23.0%)
Travel$34,777 (3.6%)
Food & Beverage$20,418 (2.1%)
Education$380.49 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $383,540 | 9 | 39.2% |
| Consulting Fee | $314,483 | 48 | 32.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $223,176 | 125 | 22.8% |
| Travel and Lodging | $34,777 | 62 | 3.6% |
| Food and Beverage | $20,418 | 911 | 2.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,950 | 1 | 0.2% |
| Education | $380.49 | 14 | 0.0% |
Payments by Type
General
$595,184
1,161 transactions
Research
$383,540
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fisher & Paykel Healthcare Limited | $268,477 | 69 | $0 (2024) |
| SomnoMed Inc. | $193,599 | 3 | $0 (2022) |
| Philips Electronics North America Corporation | $155,252 | 20 | $0 (2023) |
| GlaxoSmithKline, LLC. | $101,743 | 234 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $46,416 | 111 | $0 (2024) |
| Philips North America LLC | $34,933 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32,591 | 150 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $31,511 | 39 | $0 (2024) |
| Axsome Therapeutics, Inc. | $28,558 | 53 | $0 (2024) |
| Resmed Corp | $26,088 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,098 | 125 | Fisher & Paykel Healthcare Limited ($39,000) |
| 2023 | $126,531 | 194 | Fisher & Paykel Healthcare Inc ($36,013) |
| 2022 | $347,326 | 142 | SomnoMed Inc. ($193,599) |
| 2021 | $166,382 | 153 | Philips Electronics North America Corporation ($99,458) |
| 2020 | $73,984 | 110 | Fisher & Paykel Healthcare Limited ($36,008) |
| 2019 | $58,377 | 140 | Fisher & Paykel Healthcare Limited ($32,560) |
| 2018 | $77,611 | 157 | Fisher & Paykel Healthcare Inc ($60,588) |
| 2017 | $43,415 | 149 | Fisher & Paykel Healthcare Limited ($28,293) |
All Payment Transactions
1,170 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Fisher & Paykel Healthcare Limited | FISHER & PAYKEL HEALTHCARE (Device) | Consulting Fee | Cash or cash equivalent | $9,000.00 | General |
| Category: Sleep | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.85 | General |
| 12/09/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Pulmonology | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $43.97 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/14/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Education | In-kind items and services | $2.82 | General |
| Category: Neurology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $46.47 | General |
| Category: Narcoplepsy | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SRC-SLE(PI)-JanusAD-2021-11304 | Philips Electronics North America Corporation | $54,421 | 1 |
| Precise Fit Validation | Philips Electronics North America Corporation | $49,938 | 1 |
| SRC-SLE-Sparkle-PSG-2020-10908 | Philips Electronics North America Corporation | $40,843 | 1 |
| SRC-300401-AmaraView Benchmark | Philips North America LLC | $34,914 | 1 |
| SRC-AI-OURARING-NEWBORROWED-2021-11321 | Philips Electronics North America Corporation | $8,625 | 1 |
| Anthropometric Scanning | Fisher & Paykel Healthcare Limited | $1,200 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,665 | 1,854 | $238,061 | $109,792 |
| 2022 | 11 | 1,341 | 1,492 | $202,713 | $94,100 |
| 2021 | 12 | 1,361 | 1,531 | $216,832 | $108,184 |
| 2020 | 14 | 1,485 | 1,718 | $237,658 | $122,890 |
Total Patients
5,852
Total Services
6,595
Medicare Billing
$434,965
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 638 | 752 | $82,774 | $46,639 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 252 | $37,800 | $24,051 | 63.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $13,200 | $7,327 | 55.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 91 | 91 | $12,467 | $6,543 | 52.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 124 | 126 | $12,600 | $5,512 | 43.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 124 | 126 | $12,600 | $5,221 | 41.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 146 | 149 | $29,800 | $4,635 | 15.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 124 | 126 | $13,860 | $3,716 | 26.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 34 | 35 | $13,790 | $3,389 | 24.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 19 | 19 | $5,586 | $1,773 | 31.7% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 77 | 78 | $2,496 | $530.25 | 21.2% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 34 | 34 | $1,088 | $454.24 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 679 | 778 | $85,580 | $48,705 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 190 | $28,500 | $17,040 | 59.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $12,193 | $6,581 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $8,200 | $5,349 | 65.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 152 | 160 | $32,000 | $5,284 | 16.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 38 | 38 | $14,972 | $3,739 | 25.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 21 | 21 | $6,174 | $2,007 | 32.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 44 | 44 | $4,400 | $1,987 | 45.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 44 | 44 | $4,400 | $1,763 | 40.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 45 | 45 | $4,950 | $1,296 | 26.2% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 42 | 42 | $1,344 | $348.72 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 559 | 622 | $67,448 | $41,724 | 61.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 312 | 382 | $55,060 | $32,971 | 59.9% |
About Dr. Joseph Ojile, M.D
Dr. Joseph Ojile, M.D is a Pulmonary Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003895236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Ojile, M.D has received a total of $978,724 in payments from pharmaceutical and medical device companies, with $85,098 received in 2024. These payments were reported across 1,170 transactions from 46 companies. The most common payment nature is "" ($383,540).
As a Medicare-enrolled provider, Ojile has provided services to 5,852 Medicare beneficiaries, totaling 6,595 services with total Medicare billing of $434,965. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Saint Louis, MO
- Active Since 01/16/2006
- Last Updated 02/04/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1003895236
Products in Payments
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $127,955
- FISHER & PAYKEL HEALTHCARE (Device) $111,013
- (2383) SleepUndivided (Device) $99,406
- (1305) Mask (Device) $54,421
- TRELEGY ELLIPTA (Drug) $47,098
- SUNOSI (Drug) $35,313
- (2383) Sleep-Undivided (Device) $34,914
- QUVIVIQ (Drug) $31,511
- Sunosi (Drug) $28,558
- AIR 11 (Device) $25,962
- BREZTRI (Drug) $20,335
- AREXVY (Drug) $20,255
- Wakix (Drug) $13,317
- ANORO (Drug) $11,207
- BREZTRI AEROSPHERE (Drug) $10,853
- Dayvigo (Drug) $8,587
- WAKIX (Drug) $8,230
- ANORO ELLIPTA (Drug) $6,808
- BELSOMRA (Drug) $3,972
- Xyrem (Drug) $3,831
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Saint Louis
Dr. Alexander Chen, Md, MD
Pulmonary Disease — Payments: $859,735
Pulmonary Disease $859,735
Dr. Derek Byers, Md, MD
Pulmonary Disease — Payments: $835,202
Pulmonary Disease $835,202
Dr. Marin Kollef, Md, MD
Pulmonary Disease — Payments: $588,781
Pulmonary Disease $588,781
Dr. Praveen Chenna, Md, MD
Pulmonary Disease — Payments: $265,830
Pulmonary Disease $265,830
Dr. Murali Chakinala, Md, MD
Pulmonary Disease — Payments: $211,522
Pulmonary Disease $211,522
Dr. Janet Lee, Md, MD
Pulmonary Disease — Payments: $142,540
Pulmonary Disease $142,540